Probiotic lactobacillus strains for use in treating urinary tract infections

The new strains Lactobacillus plantarum CECT8675, CECT8676, CECT8677 and CECT8678 and mutants thereof are provided. The strains present as key advantage that they have the ability to antagonize the urogenital pathogens Staphylococcus saprophyticus, Escherichia coli, Klebsiella pneumoniae and Proteus...

Full description

Saved in:
Bibliographic Details
Main Authors SANTAS GUTIÉRREZ, JONATAN, LÁZARO MALLÉN, ELISABET, CUÑÉ CASTELLANA, JORDI
Format Patent
LanguageEnglish
French
German
Published 07.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The new strains Lactobacillus plantarum CECT8675, CECT8676, CECT8677 and CECT8678 and mutants thereof are provided. The strains present as key advantage that they have the ability to antagonize the urogenital pathogens Staphylococcus saprophyticus, Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis, which are useful in the management of UTI and other related conditions of the urogenital tract. Additionally, the strains of the present invention have the capacity to survive at high concentrations of fosfomycin, antibiotic typically used for managing UTI. In summary, the strains of the present invention can be co-administered with the antibiotic fosfomycin. The present invention also relates to the compositions and products comprising the new strains.
Bibliography:Application Number: EP20150382051